TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12807410

Group type: EXPERIMENTAL
Intervention: Rightward-moving sounds with falling pitch and leftward-moving sounds with rising pitch (induction phase)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual stimulus moving in the opposite direction of the sound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual motion combined with a stationary sound
Number of subjects: 0
Study: 11057797

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard care (for nonresponders)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 25
Study: 8646867

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate ointment, 0.005%
Number of subjects: 92

Group type: COMPARATOR
Intervention: Betamethasone-17,21-dipropionate ointment, 0.05%
Number of subjects: 92
Study: 2049246

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6380348

Group type: EXPERIMENTAL
Intervention: Trental 400
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31178433

Group type: EXPERIMENTAL
Intervention: Insulin glargine followed by metformin
Number of subjects: 223

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 223
Study: 29924461

Group type: EXPERIMENTAL
Intervention: Active counterpulsation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 28
Study: 27295871

Group type: EXPERIMENTAL
Intervention: Stannous-containing sodium fluoride dentifrice, advanced manual toothbrush, and CPC rinse
Number of subjects: 35

Group type: COMPARATOR
Intervention: Negative control regimen (0.243% sodium fluoride dentifrice and soft flat trim manual toothbrush)
Number of subjects: 35
Study: 24953766

Group type: EXPERIMENTAL
Intervention: Sodium valproate 15-20 mg/kg + 300 mg allopurinol twice a day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sodium valproate 15-20 mg/kg + placebo
Number of subjects: 57
Study: 23161092

Group type: EXPERIMENTAL
Intervention: Personalised feedback alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personalised feedback in combination with peer support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 20600551

Group type: EXPERIMENTAL
Intervention: Chitosan treatment at concentrations of 2.5mg/mL and 5.0mg/mL for 60s to 90s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chitosan treatment
Number of subjects: 0
Study: 17903231

Group type: EXPERIMENTAL
Intervention: 1‐day course at local hospital
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 1‐day course at simulation centre
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 2‐day course with teamwork training at local hospital
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 2‐day course with teamwork training at simulation centre
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 140
Study: 16282843

Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone supplementation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 12121395

Group type: EXPERIMENTAL
Intervention: Desonide 0.05% lotion
Number of subjects: 81

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 81
Study: 10789216

Group type: EXPERIMENTAL
Intervention: Low energy diet
Number of subjects: 86
Study: 8815553

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 283

Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 283
Study: 2195084

Group type: EXPERIMENTAL
Intervention: Higher levels of intrinsic motivation
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: Lower levels of extrinsic motivation
Number of subjects: 1368
Study: 518220

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (100 mg/day)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Spironolactone (400 mg/day)
Number of subjects: 29
Study: 31993664

Group type: EXPERIMENTAL
Intervention: Controlled e‐cigarette device with flavored or unflavored e‐liquids
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Assigned e‐liquid flavor
Number of subjects: 49
Study: 31395295

Group type: EXPERIMENTAL
Intervention: LBBB
Number of subjects: 22067

Group type: EXPERIMENTAL
Intervention: L-IVCD
Number of subjects: 22067

Group type: EXPERIMENTAL
Intervention: LVCD (LBBB or L-IVCD)
Number of subjects: 22067
Study: 25168967

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23273697

Group type: EXPERIMENTAL
Intervention: Preoperative IMA embolization
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (no embolization)
Number of subjects: 266
Study: 21470283

Group type: EXPERIMENTAL
Intervention: rhGH (0.067 mg/kg per day) as daily subcutaneous injections
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no rhGH)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: rhGH group
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 17658525

Group type: EXPERIMENTAL
Intervention: 17alpha-hydroxyprogesterone caproate (17-HPC) 250 mg, i.m., 1 day before ET
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no injections)
Number of subjects: 125
Study: 16846869

Group type: EXPERIMENTAL
Intervention: Non-closure of peritoneum
Number of subjects: 54

Group type: COMPARATOR
Intervention: Closure of peritoneum
Number of subjects: 54
Study: 14503057

Group type: EXPERIMENTAL
Intervention: Qinwen Baidu Decoction (QBD)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional therapy (Control)
Number of subjects: 46
Study: 11155154

Group type: EXPERIMENTAL
Intervention: Low-dose IFNalpha-2b (3 MU) three times weekly for 3 months (Group 2)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: High-dose IFNalpha-2b (6-10 MU) three times weekly for 3 months (Group 3)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No specific treatment (Control Group 1)
Number of subjects: 53
Study: 9386710

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopy (VATS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 39
Study: 7909797

Group type: EXPERIMENTAL
Intervention: Propranolol (240 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3226529

Group type: EXPERIMENTAL
Intervention: Methylphenidate 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secobarbital 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diphenhydramine 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Central nervous system depressants (general)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual Analog Mood Scale (VAMS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Profile of Mood States (POMS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stroop
Number of subjects: 0
Study: 2012448

Group type: EXPERIMENTAL
Intervention: Sublingual captopril (25 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sublingual nifedipine (10 mg)
Number of subjects: 20
Study: 63749

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 750 mg desferrioxamine before transfusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intramuscular injection of 750 mg desferrioxamine after transfusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of 750 mg desferrioxamine over 24 hours
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of desferrioxamine after transfusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of 1500 mg desferrioxamine over 24 hours
Number of subjects: 12
Study: 30763404

Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) over the DLPFC, 1.5 mA for 20 minutes during three consecutive days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation (same electrode placement as active stimulation)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) over the DLPFC
Number of subjects: 22
Study: 28731567

Group type: COMPARATOR
Intervention: 8-week sham acupuncture treatment
Number of subjects: 71

Group type: COMPARATOR
Intervention: Increased global efficiency before starting clinical treatment
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nodal efficiency in white matter network
Number of subjects: 71
Study: 26648691

Group type: EXPERIMENTAL
Intervention: Letrozole + HMG
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: CC + HMG
Number of subjects: 255

Group type: COMPARATOR
Intervention: HMG only
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Letrozole + HMG and CC + HMG
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Letrozole + HMG, CC + HMG, HMG only
Number of subjects: 255
Study: 23225160

Group type: EXPERIMENTAL
Intervention: Conventional laparoscopic set-up
Number of subjects: 36

Group type: COMPARATOR
Intervention: SILS set-up with straight instruments
Number of subjects: 36

Group type: COMPARATOR
Intervention: SILS set-up with articulating instruments
Number of subjects: 36

Group type: COMPARATOR
Intervention: SILS set-up after prior training with conventional laparoscopy
Number of subjects: 36
Study: 21239405

Group type: EXPERIMENTAL
Intervention: Regression of ECG strain
Number of subjects: 7265

Group type: EXPERIMENTAL
Intervention: Persistence of ECG strain
Number of subjects: 7265

Group type: EXPERIMENTAL
Intervention: Development of new ECG strain
Number of subjects: 7265

Group type: COMPARATOR
Intervention: No ECG strain
Number of subjects: 7265
Study: 19276209

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Economic tools for addressing ICD cost issues
Number of subjects: 0
Study: 17164574

Group type: EXPERIMENTAL
Intervention: Dorzolamide
Number of subjects: 36

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 36
Study: 14992088

Group type: EXPERIMENTAL
Intervention: 2,000 mg ascorbic acid intravenously before applying local anesthetics
Number of subjects: 72

Group type: COMPARATOR
Intervention: Prilocaine and bupivacaine for plexus anesthesia
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0.5 mg/ml ascorbic acid in vitro with o-toluidine
Number of subjects: 72

Group type: COMPARATOR
Intervention: 5 mg/ml ascorbic acid in vitro with o-toluidine
Number of subjects: 72
Study: 10898050

Group type: EXPERIMENTAL
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 22
Study: 9123949

Group type: EXPERIMENTAL
Intervention: Motivational support program
Number of subjects: 43

Group type: COMPARATOR
Intervention: Structured diabetes education program only
Number of subjects: 43
Study: 1496538

Group type: EXPERIMENTAL
Intervention: Fish oil (daily 6 g, 30% C20:5 omega‐3 and 20% C22:6 omega‐3 as their methyl esters)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Coconut oil (daily 6g [63% C8:0 and 36% C10:0])
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Fish oil (daily 6 g)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Coconut oil (daily 6g)
Number of subjects: 88
Study: 6363949

Group type: EXPERIMENTAL
Intervention: 250 mg methylprednisolone (MP) daily for 4 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1,000 mg methylprednisolone (MP) daily for 4 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 250 mg methylprednisolone (MP)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1,000 mg methylprednisolone (MP)
Number of subjects: 18
Study: 31607515

Group type: EXPERIMENTAL
Intervention: BioFire FilmArray Respiratory Panel (FA RP)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Luminex NxTAG Respiratory Pathogen Panel (NxTAG RPP)
Number of subjects: 133
Study: 26961365

Group type: EXPERIMENTAL
Intervention: Tailored care package over 1.5 years
Number of subjects: 903

Group type: COMPARATOR
Intervention: Usual practice (control)
Number of subjects: 903
Study: 26545539

Group type: EXPERIMENTAL
Intervention: Caffeine intake (3 mg/kg‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (sucralose)
Number of subjects: 7
Study: 23237135

Group type: EXPERIMENTAL
Intervention: IVUS guided DES implantation
Number of subjects: 284

Group type: COMPARATOR
Intervention: Angiography guided DES implantation
Number of subjects: 284
Study: 21827318

Group type: EXPERIMENTAL
Intervention: SAP with LGS
Number of subjects: 21

Group type: COMPARATOR
Intervention: SAP without LGS
Number of subjects: 21
Study: 19318453

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise training
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-intensity exercise training
Number of subjects: 34

Group type: COMPARATOR
Intervention: No exercise training (control)
Number of subjects: 34
Study: 16750468

Group type: EXPERIMENTAL
Intervention: Cilomilast 15 mg BID (study 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cilomilast 15 mg BID (study 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cilomilast (both studies)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (study 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (study 2)
Number of subjects: 36
Study: 14755134

Group type: COMPARATOR
Intervention: Reboxetine (4 mg) alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of reboxetine (4 mg) and mirtazapine (15 mg)
Number of subjects: 12
Study: 11030508

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX) injections to the elbow and wrist flexors
Number of subjects: 2
Study: 9085752

Group type: EXPERIMENTAL
Intervention: IVUS-guided coronary stent placement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IVUS-guided therapy
Number of subjects: 0
Study: 7902645

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 3911699

Group type: EXPERIMENTAL
Intervention: Cholecystokinin (CCK)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31333252

Group type: EXPERIMENTAL
Intervention: Evaluation of drug literature abstracts
Number of subjects: 59
Study: 31199792

Group type: EXPERIMENTAL
Intervention: Community health volunteers (CHVs) home visits
Number of subjects: 1956

Group type: COMPARATOR
Intervention: Control communities (no CHVs home visits)
Number of subjects: 1956

Group type: EXPERIMENTAL
Intervention: Community health volunteers (CHVs) home visits with ≥70% coverage and ≥30-minute visit duration
Number of subjects: 1956
Study: 27572887

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) - Tinzaparin sodium 4500 IU subcutaneous daily injection with 500 µg folic acid once daily orally, started once positive pregnancy test till the 20th week of gestation.
Number of subjects: 300

Group type: COMPARATOR
Intervention: Folic acid alone (same dosage as in intervention group).
Number of subjects: 300
Study: 26321751

Group type: EXPERIMENTAL
Intervention: Flare present
Number of subjects: 508
Study: 22813429

Group type: EXPERIMENTAL
Intervention: Ketamine (specific dosage and duration not mentioned)
Number of subjects: 0
Study: 21166928

Group type: EXPERIMENTAL
Intervention: High dose atorvastatin (40 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18359417

Group type: EXPERIMENTAL
Intervention: Pseudomonas species
Number of subjects: 739

Group type: EXPERIMENTAL
Intervention: Multidrug-resistant (MDR) organisms
Number of subjects: 739

Group type: COMPARATOR
Intervention: Pseudomonas
Number of subjects: 739

Group type: COMPARATOR
Intervention: MDR organisms
Number of subjects: 739

Group type: COMPARATOR
Intervention: Appropriate empirical antibiotic therapy
Number of subjects: 739

Group type: COMPARATOR
Intervention: 28-day mortality
Number of subjects: 739

Group type: COMPARATOR
Intervention: Hospital mortality
Number of subjects: 739

Group type: COMPARATOR
Intervention: Duration of mechanical ventilation
Number of subjects: 739

Group type: COMPARATOR
Intervention: ICU length of stay
Number of subjects: 739

Group type: COMPARATOR
Intervention: Hospital length of stay
Number of subjects: 739
Study: 16431933

Group type: EXPERIMENTAL
Intervention: Post-exercise assessment after marathon completion
Number of subjects: 14
Study: 14499416

Group type: EXPERIMENTAL
Intervention: rectal placebo (RP)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: rectal lidocaine (RL)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: oral lidocaine (OL)
Number of subjects: 13

Group type: COMPARATOR
Intervention: natural history (NH)
Number of subjects: 13

Group type: COMPARATOR
Intervention: rectal nocebo (RN)
Number of subjects: 13
Study: 10853679

Group type: EXPERIMENTAL
Intervention: Supervised walking exercise (4-week program)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 40
Study: 9239162

Group type: EXPERIMENTAL
Intervention: Granisetron (KYT) administered for 5 consecutive days (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Granisetron (KYT) administered on day 1 (Group A)
Number of subjects: 40
Study: 12959314

Group type: EXPERIMENTAL
Intervention: Intramuscular picenadol 50 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pethidine 100 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3546747

Group type: EXPERIMENTAL
Intervention: Discontinue drug therapy and reduce overweight, excess salt, and alcohol (Group 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Discontinue drug therapy with no nutritional program (Group 2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continue drug therapy with no nutritional program (Group 3)
Number of subjects: 0
Study: 28988424

Group type: EXPERIMENTAL
Intervention: Impella 2.5 axial flow pump
Number of subjects: 445

Group type: COMPARATOR
Intervention: Intra-aortic balloon pump
Number of subjects: 445
Study: 28934945

Group type: EXPERIMENTAL
Intervention: Aqua walking (AW)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treadmill/track walking (TW)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-exercise control (CON)
Number of subjects: 60
Study: 26241693

Group type: EXPERIMENTAL
Intervention: Freestyle Navigator II CGM
Number of subjects: 57
Study: 23164722

Group type: EXPERIMENTAL
Intervention: Single suture anchors
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Double suture anchors
Number of subjects: 50
Study: 21044929

Group type: EXPERIMENTAL
Intervention: Minilaparotomy (MC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 60
Study: 18474682

Group type: EXPERIMENTAL
Intervention: Plasma Tanshinol (TSL) from cardiotonic pills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urinary Tanshinol (TSL) from cardiotonic pills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urinary recovery of Tanshinol (TSL) in humans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Absorption rate and bioavailability of Tanshinol (TSL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Renal excretion of Tanshinol (TSL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCA (Protocatechuic aldehyde)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other phenolic acids from Danshen
Number of subjects: 0
Study: 17052637

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg (1 mL) added to articaine 4%, 1:100:000 epinephrine, 1.5 cartridges (2.7 mL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Articaine 4%, 1:100:000 epinephrine, 1.5 cartridges (2.7 mL) and saline (1 mL)
Number of subjects: 48
Study: 14603582

Group type: EXPERIMENTAL
Intervention: Combination of omeprazole plus diclofenac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPI with other nonselective NSAIDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective COX‐2 inhibitor with a PPI or misoprostol
Number of subjects: 0
Study: 14635273

Group type: EXPERIMENTAL
Intervention: Monarch valgus loading knee brace
Number of subjects: 5

Group type: COMPARATOR
Intervention: Unbraced condition
Number of subjects: 5
Study: 7710561

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (14 mmol/l)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Euglycaemia (5 mmol/l)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypoglycaemia (2.5 mmol/l)
Number of subjects: 10
Study: 1709903

Group type: EXPERIMENTAL
Intervention: Nebulized heparin (800 IU per kg b.w.) administered by inhalation one day prior to surgery
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Nebulized heparin (800 IU per kg b.w.) + long acting anabolic steroid (50 mg nandrolone phenylpropionate) intramuscularly
Number of subjects: 183

Group type: COMPARATOR
Intervention: 5000 IU heparin subcutaneously on hr prior to surgery and every 12 h for the next 5 postoperative days
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Nebulized heparin (800 IU per kg b.w.)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Nebulized heparin (800 IU per kg b.w.) + long acting anabolic steroid (50 mg nandrolone phenylpropionate)
Number of subjects: 183
Study: 345412

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 143

Group type: COMPARATOR
Intervention: Diazepam alone
Number of subjects: 143
Study: 31621973

Group type: EXPERIMENTAL
Intervention: Model-less approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Printed model digital approach
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both workflows
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both materials
Number of subjects: 40
Study: 28731561

Group type: EXPERIMENTAL
Intervention: High glycaemic index (GI)
Number of subjects: 1618

Group type: EXPERIMENTAL
Intervention: Energy-adjusted glycaemic load (GL)
Number of subjects: 1618
Study: 26695922

Group type: EXPERIMENTAL
Intervention: Ambroxol (30 mg three times per day) and Essenciale (600 mg twice daily) for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Basic therapy only
Number of subjects: 60